State how risk factors include heredity, obesity, black race, and hypertension

State how risk factors include heredity, obesity, black race, and hypertension

Tashura, I do have experience with uterine fibroids. Age is a factor for this disorder. It does not occur before a female has her first menstrual cycle, and not occur after menopause. Huether & McCance state how risk factors include heredity, obesity, black race, and hypertension (2017). I have had these and did not have the pain you refer to. I was bleeding very heavily, multiple physicians thought it was due to birth control pills. After being admitted into the hospital, and after a vaginal ultrasound, I was finally diagnosed. Physicians told me I could still get pregnant but would have to be very careful. According to womenshealth.gov, treatment can include medications or surgery (n.d.). Medications include progesterone and gonadotropin-releasing hormone agonists which stop or decrease bleeding. Surgical interventions include myomectomy, hysterectomy, or ablations. Yearly pelvic exams did not help with diagnosis, only when I was admitted to the hospital with major blood loss, and needed a blood transfusion, did they finally diagnose me after an ultrasound was done. I chose a myomectomy. A big similarity between your chosen disorders is that there is no cure. If a fibroid is surgically removed it can grow back. Mine did and I finally had a hysterectomy. Both these disorders can be managed but never cured. Huether, S. E., & McCance, K. L. (2017). Understanding pathophysiology (6th ed.). St. Louis, MO: Mosby. Womenshealth.gov (n.d.). Uterine fibroids. Retrieved from https://www.womenshealth.gov/a-z-topics/uterine-fibroids please respond to this discussion answer this is what i submitted and the student responded back toReproductive Systems The reproductive system is a collection of internal as well as external organs in both females and males. Reproductive system disease refers to any disorder that affects the reproductive system of a person. Women usually experience different reproductive health issues and conditions which range from pregnancy, menopause to gynecological issues. This paper discusses uterine fibroids and polycystic ovary syndrome as two disorders that affect the female reproductive system. Uterine Fibroids These are benign tumors that usually originate in the uterus. Most of the women with this disorder are usually unaware of its presence, but they can, at times, cause abnormal bleeding from the uterus and pain. Other symptoms of this disorder include pain during sex, urinating often, lower back pain, painful or heavy periods, and reproductive problems such as multiple miscarriages. The tumors are normally made of fibroblasts, smooth muscle cells as well as other materials that grow in or on the wall of the womb or uterus. For women who are in the childbearing age, uterine fibroids are the most common non-cancerous tumors. They grow rapidly during pregnancy because, during the pregnancy period, the hormone levels tend to be high. Although it is not known what causes the disorder, evidence suggests that it is caused by several factors, which include growth hormones, major stresses, genetics, and micronutrients (Stewart et al., 2016). Polycystic Ovary Syndrome This disorder usually develops when the adrenal glands or ovaries produce more male hormones, which affect the ability of the ovary to develop and release eggs. It is mainly caused by hormonal imbalance and affects girls and women of reproductive age. This disorder can cause a person to experience skin changes, suffer from infertility, and have cysts in the ovaries. Women who suffer from this disorder also experience problems with their metabolism. Most of the symptoms associated with this disorder are caused by higher-than-normal levels of Androgens or problems with insulin. According to past research, some of the factors that contribute to the development of this disorder include environmental and genetic factors. The condition is likely caused by a mutation or change in one or more genes, considering that it runs in families (Azziz et al., 2016). Similarities One of the similarities of these two disorders is that they both trigger the formation of growth in female reproductive organs. Another similarity is that polycystic ovarian syndrome causes cysts that are not cancerous, and on the other hand, fibroids are benign and not cancerous as well. These two reproductive disorders have been associated with hormone imbalances, and they both affect menstrual cycles, impair fertility, and also cause pelvic pain. Differences The main difference between these two disorders is that polycystic ovary syndrome is caused by the development of uterine cysts on the ovaries, which is usually caused by a hormonal imbalance. On the other hand, growths within the uterus cause uterine fibroids (Hunt, , Sathyanarayana, Fowler, & Trasande, 2016). Age and its Impact Age can impact the diagnosis and treatment for uterine fibroids because the disorder does not affect girls before puberty and does not also affect women who have gone through menopause. The disorder, in most cases, affects women who are between the age of 30 and 40 years. Uterine fibroids can be diagnosed using a pelvic exam and ultrasound. CT scans and MRIs can also be used. Some of the treatment options for this disorder include uterine artery embolization, surgery, and the use of medications such as danazol and mifepristone (Stewart et al., 2016). On the other hand, age impacts the diagnosis and treatment for polycystic ovary syndrome because it can occur at any age. Health providers diagnose this condition if a person has at least two of the main symptoms. To confirm the diagnoses, the following tests can be carried out a physical exam, pelvic exam, ultrasound, and blood tests. The disorder can be treated using birth control pills and other medicines such as clomiphene and metformin. Surgery can also help in the treatment plan when other treatment options fail to work. References Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S., Legro, R. S., … & Yildiz, B. O. (2016). Polycystic ovary syndrome. Nature reviews Disease primers, 2(1), 1-18. Hunt, P. A., Sathyanarayana, S., Fowler, P. A., & Trasande, L. (2016). Female reproductive disorders, diseases, and costs of exposure to endocrine disrupting chemicals in the European Union. The Journal of Clinical Endocrinology & Metabolism, 101(4), 1562-1570. Stewart, E. A., Laughlin-Tommaso, S. K., Catherino, W. H., Lalitkumar, S., Gupta, D., & Vollenhoven, B. (2016). Uterine fibroids. Nature reviews Disease primers, 2(1), 1-18.